Perrigo Co. (PRGO) shares rose to their highest level on record in Tel Aviv, closing the price gap with U.S.-traded stock in the company.
The shares of the largest U.S. maker of generic over-the- counter drugs advanced 3.1 percent to 402 shekels, or the equivalent of $105.7, at the 4:30 p.m. close in Tel Aviv, the highest since the shares started trading in 2005. Perrigo closed at $105.8 in New York on March 2.